| CC50a(μM) | Anti-viral activitybagainst |
---|
HSV-2 | HSV-1 KOS | HSV-1 ACGr4 | HSV-1 dlsptk | HSV-1 dxpIII |
---|
IC50(μM) | SIc | IC50(μM) | SIc | IC50(μM) | SIc | IC50(μM) | SIc | IC50(μM) | SIc |
---|
IPAD
| 39.71 | 18.01 | 2.20 | 16.96 | 2.34 | 17.89 | 2.22 | 16.86 | 2.36 | 17.12 | 2.32 |
ACV
| >6,400 | 0.80 | >8,000 | 0.49 | >13,061 | 575.91 | >11.11 | 450.25 | >14.21 | 161.45 | >39.64 |
- The value represents mean of three independent experiments.
- aCytotoxic effect was determined using the MTT assay. CC50 was the concentration reducing cell viability by 50% relative to controls.
- bAnti-viral activity was determined using the CPE reduction assay. IC50 was the concentration that reduced HSV-induced CPE formation by 50% relative to controls.
- cSI (selective index) was calculated as the ratio of CC50 to IC50.